JOP20200326A1 - مشتقات تترا هيدرو ثينوبيريدين بها استبدال بـ n واستخداماتها - Google Patents
مشتقات تترا هيدرو ثينوبيريدين بها استبدال بـ n واستخداماتهاInfo
- Publication number
- JOP20200326A1 JOP20200326A1 JOP/2020/0326A JOP20200326A JOP20200326A1 JO P20200326 A1 JOP20200326 A1 JO P20200326A1 JO P20200326 A JOP20200326 A JO P20200326A JO P20200326 A1 JOP20200326 A1 JO P20200326A1
- Authority
- JO
- Jordan
- Prior art keywords
- substituted
- tetrahydrothienopyridine derivatives
- derivatives
- substituted tetrahydrothienopyridine
- treating
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/4365—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system having sulfur as a ring hetero atom, e.g. ticlopidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/22—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound oxygen atoms
- C07C311/29—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound oxygen atoms having the sulfur atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Virology (AREA)
- Epidemiology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862687068P | 2018-06-19 | 2018-06-19 | |
| PCT/IB2019/055121 WO2019244047A1 (en) | 2018-06-19 | 2019-06-18 | N-substituted tetrahydrothienopyridine derivatives and uses thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JOP20200326A1 true JOP20200326A1 (ar) | 2020-12-14 |
Family
ID=67841114
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JOP/2020/0326A JOP20200326A1 (ar) | 2018-06-19 | 2019-06-18 | مشتقات تترا هيدرو ثينوبيريدين بها استبدال بـ n واستخداماتها |
Country Status (24)
| Country | Link |
|---|---|
| US (3) | US12012417B2 (https=) |
| EP (2) | EP4169925B1 (https=) |
| JP (1) | JP7328260B2 (https=) |
| KR (1) | KR102835904B1 (https=) |
| CN (1) | CN112313237A (https=) |
| AU (1) | AU2019291488B2 (https=) |
| BR (1) | BR112020025696A2 (https=) |
| CA (1) | CA3100957A1 (https=) |
| CL (1) | CL2020003248A1 (https=) |
| CR (1) | CR20200618A (https=) |
| CU (1) | CU20200100A7 (https=) |
| EA (1) | EA202190046A1 (https=) |
| EC (1) | ECSP20080995A (https=) |
| ES (2) | ES3062606T3 (https=) |
| IL (1) | IL279441B2 (https=) |
| JO (1) | JOP20200326A1 (https=) |
| MA (1) | MA52976A (https=) |
| MX (1) | MX2020013852A (https=) |
| MY (1) | MY201990A (https=) |
| PE (1) | PE20210097A1 (https=) |
| PH (1) | PH12020552185A1 (https=) |
| SA (1) | SA520420809B1 (https=) |
| SG (1) | SG11202012625PA (https=) |
| WO (1) | WO2019244047A1 (https=) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3663299B1 (en) * | 2017-08-01 | 2023-03-08 | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Bicyclic compound acting as ror gamma inhibitor |
| BR112020025696A2 (pt) | 2018-06-19 | 2021-03-16 | Novartis Ag | Derivados de tetra-hidrotienopiridina n-substituída e usos dos mesmos |
| USD1006154S1 (en) * | 2023-06-27 | 2023-11-28 | Qiongfang Mao | Cable crossover attachment |
| WO2025238553A1 (en) | 2024-05-14 | 2025-11-20 | Novartis Ag | Dosing regimens for n-(3-cyano-5-(cyclohexylmethyl)-6,6-dimethyl-4,5,6,7-tetrahydrothieno[3,2-c]pyridin-2-yl)-2-(4-sulfamoylphenyl)acetamide for use in treating or preventing a dengue virus disease or disorder |
| WO2025253267A1 (en) | 2024-06-06 | 2025-12-11 | Janssen Pharmaceuticals, Inc. | Combination of mosnodenvir and close analogs with nitd-688 for use in the treatment and prevention of dengue disease |
Family Cites Families (39)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5807A (en) | 1848-09-26 | Brake fob cabs | ||
| US6344A (en) | 1849-04-17 | Driving-bobbin | ||
| US498178A (en) | 1893-05-23 | William valentine leonard | ||
| US4656A (en) | 1846-07-24 | Improvement in potato-plows | ||
| US8766A (en) | 1852-02-24 | Appabatus for lightening vessels | ||
| US54472A (en) | 1866-05-01 | Improved blacking-brush | ||
| US6054472A (en) | 1996-04-23 | 2000-04-25 | Vertex Pharmaceuticals, Incorporated | Inhibitors of IMPDH enzyme |
| US5807876A (en) | 1996-04-23 | 1998-09-15 | Vertex Pharmaceuticals Incorporated | Inhibitors of IMPDH enzyme |
| CA2252465C (en) | 1996-04-23 | 2007-07-03 | Vertex Pharmaceuticals Incorporated | Urea derivatives as inhibitors of impdh enzyme |
| DK0966465T3 (da) | 1997-03-14 | 2003-10-20 | Vertex Pharma | Inhibitorer af IMPDH-enzymer |
| CA2367017C (en) | 1999-03-19 | 2009-05-26 | Vertex Pharmaceuticals Incorporated | Inhibitors of impdh enzyme |
| GB0114185D0 (en) | 2001-06-12 | 2001-08-01 | Protherics Molecular Design Lt | Compounds |
| DE60236428D1 (de) | 2001-05-21 | 2010-07-01 | Monsanto Technology Llc | Etheramin-tenside enthaltende pestizidkonzentrate |
| US20030232994A1 (en) | 2001-10-04 | 2003-12-18 | Shao-Po Lu | Bicyclic thiophene derivatives and combinatorial libraries thereof |
| CA2498399A1 (en) | 2002-09-12 | 2004-03-25 | Merck & Co., Inc. | Method of treating diabetes and related conditions |
| US7138529B2 (en) * | 2003-04-16 | 2006-11-21 | Hoffmann-La Roche Inc. | Substituted 3-cyanothiophene acetamides as glucagon receptor antagonists |
| GB0324653D0 (en) | 2003-10-22 | 2003-11-26 | Syngenta Participations Ag | Fungicides |
| ES2309765T3 (es) | 2004-05-28 | 2008-12-16 | 4Sc Ag | Tetrahidropiridotiofenos. |
| AU2005272646A1 (en) | 2004-08-12 | 2006-02-23 | Wyeth | Combination therapy for diabetes, obesity, and cardiovascular diseases using GDF-8 inhibitors |
| EP1851229A1 (en) | 2005-02-09 | 2007-11-07 | Nycomed GmbH | Tetrahydropyridothiophenes for the treatment of proliferative diseases such as cancer |
| AU2006212179A1 (en) | 2005-02-11 | 2006-08-17 | 4Sc Ag | Tetrahydropyridothiophenes as antripoliferative agents for the treatment of cancer |
| BRPI0610283A2 (pt) | 2005-05-13 | 2010-10-19 | Virochem Pharma Inc | composto, uso do mesmo na preparação de um medicamento para o tratamento ou prevenção de uma infecção por vìrus de hepatite c, composição farmacêutica e combinação farmacêutica |
| US7714136B2 (en) | 2005-05-25 | 2010-05-11 | 4Sc Ag | Tetrahydropyridothiophenes |
| US7763728B2 (en) | 2005-05-25 | 2010-07-27 | 4Sc Ag | Tetrahydropyridothiophenes |
| US7932391B2 (en) | 2005-09-08 | 2011-04-26 | Zhejiang Hauhai Pharmaceutical Co., Ltd. | Method for the preparation of clopidogrel and its analogues of methyl-tetrahydrothieno[3,2-C]pyridine acetate |
| WO2008020024A1 (en) | 2006-08-16 | 2008-02-21 | 4Sc Ag | Ntetrahydropyridothiophene derivatives for the treatment of cancer |
| WO2008020045A1 (en) | 2006-08-16 | 2008-02-21 | 4Sc Ag | Tetrahydrobenzothiophene derivatives |
| WO2008067222A1 (en) | 2006-11-28 | 2008-06-05 | Kalypsys, Inc. | Heterocyclic modulators of tgr5 |
| CA2709784A1 (en) | 2007-12-21 | 2009-07-09 | University Of Rochester | Method for altering the lifespan of eukaryotic organisms |
| MX2011008988A (es) | 2009-02-27 | 2011-12-16 | Siga Technologies Inc | Derivados de tienopiridina para el tratamiento y prevencion de infecciones por el virus del dengue. |
| US20130129677A1 (en) * | 2009-02-27 | 2013-05-23 | Siga Technologies, Inc. | Thienopyridine Derivatives for the Treatment and Prevention of Dengue Virus Infections |
| JP5701655B2 (ja) | 2011-03-29 | 2015-04-15 | 奈良県 | 植物精油中のトロポロン類及び／又はフェノール類の金属錯体化方法 |
| AP2014007595A0 (en) | 2011-09-30 | 2014-04-30 | Kineta Inc | Anti-viral compounds |
| US10844051B2 (en) | 2015-07-22 | 2020-11-24 | The Royal Institution For The Advancement Of Learning/Mcgill University | Substituted oxazoles for the treatment of cancer |
| CN108689987A (zh) * | 2017-04-05 | 2018-10-23 | 浙江海正药业股份有限公司 | 一种磺胺类衍生物及其制备方法和用途 |
| CN110753682B (zh) * | 2017-05-22 | 2023-06-30 | 杨森制药公司 | 作为登革热病毒复制抑制剂的经取代的吲哚啉衍生物 |
| EP3663299B1 (en) | 2017-08-01 | 2023-03-08 | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Bicyclic compound acting as ror gamma inhibitor |
| CN108191885B (zh) * | 2018-01-29 | 2020-08-04 | 华东师范大学 | 一类哌啶并噻吩类小分子有机化合物及其应用 |
| BR112020025696A2 (pt) | 2018-06-19 | 2021-03-16 | Novartis Ag | Derivados de tetra-hidrotienopiridina n-substituída e usos dos mesmos |
-
2019
- 2019-06-18 BR BR112020025696-0A patent/BR112020025696A2/pt unknown
- 2019-06-18 MA MA052976A patent/MA52976A/fr unknown
- 2019-06-18 JP JP2020570065A patent/JP7328260B2/ja active Active
- 2019-06-18 KR KR1020217001077A patent/KR102835904B1/ko active Active
- 2019-06-18 CU CU2020000100A patent/CU20200100A7/es unknown
- 2019-06-18 IL IL279441A patent/IL279441B2/en unknown
- 2019-06-18 CR CR20200618A patent/CR20200618A/es unknown
- 2019-06-18 SG SG11202012625PA patent/SG11202012625PA/en unknown
- 2019-06-18 MX MX2020013852A patent/MX2020013852A/es unknown
- 2019-06-18 PE PE2020002060A patent/PE20210097A1/es unknown
- 2019-06-18 ES ES22207844T patent/ES3062606T3/es active Active
- 2019-06-18 EA EA202190046A patent/EA202190046A1/ru unknown
- 2019-06-18 MY MYPI2020006010A patent/MY201990A/en unknown
- 2019-06-18 WO PCT/IB2019/055121 patent/WO2019244047A1/en not_active Ceased
- 2019-06-18 US US17/253,755 patent/US12012417B2/en active Active
- 2019-06-18 CA CA3100957A patent/CA3100957A1/en active Pending
- 2019-06-18 ES ES19762467T patent/ES2941946T3/es active Active
- 2019-06-18 EP EP22207844.6A patent/EP4169925B1/en active Active
- 2019-06-18 CN CN201980040348.4A patent/CN112313237A/zh active Pending
- 2019-06-18 EP EP19762467.9A patent/EP3810613B1/en active Active
- 2019-06-18 JO JOP/2020/0326A patent/JOP20200326A1/ar unknown
- 2019-06-18 AU AU2019291488A patent/AU2019291488B2/en active Active
-
2020
- 2020-12-15 EC ECSENADI202080995A patent/ECSP20080995A/es unknown
- 2020-12-15 CL CL2020003248A patent/CL2020003248A1/es unknown
- 2020-12-15 SA SA520420809A patent/SA520420809B1/ar unknown
- 2020-12-16 PH PH12020552185A patent/PH12020552185A1/en unknown
-
2024
- 2024-05-07 US US18/657,123 patent/US12331060B2/en active Active
-
2025
- 2025-05-09 US US19/204,147 patent/US20260070920A1/en active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JOP20200326A1 (ar) | مشتقات تترا هيدرو ثينوبيريدين بها استبدال بـ n واستخداماتها | |
| CY1125230T1 (el) | Οξυστερολες και μεθοδοι χρησης αυτων | |
| MX2019004578A (es) | Oxisteroles y metodos de uso de los mismos. | |
| ZA202005326B (en) | Heteroaryl compounds as type ii irak inhibitors and uses hereof | |
| JOP20180098A1 (ar) | : مركبات علاجية مفيدة للوقاية من أو علاج الإصابة بفيروس نقص المناعة البشرية | |
| EA201591457A8 (ru) | Терапевтические соединения | |
| EA201991349A1 (ru) | Тетрациклические гетероциклические соединения, полезные в качестве ингибиторов интегразы вич | |
| NZ631726A (en) | Therapeutic compounds for the treatment of viral infections | |
| EA201690669A8 (ru) | Замещенные производные хинолизина, которые можно использовать как ингибиторы интегразы вич | |
| MX377277B (es) | Derivados de fenoximetilo. | |
| MX376833B (es) | Oxiesteroles y metodos de uso de los mismos. | |
| PH12015502443A1 (en) | 6-bridged heteroaryldihydropyrimidines for the treatment and prophylaxis of hepatitis b virus infection | |
| NZ631738A (en) | (hetero) arylacetamide derivatives as antiretroviral agents | |
| EA201691261A1 (ru) | Новые дигидрохинолизиноны для лечения и профилактики инфекции, вызванной вирусом гепатита b | |
| MY188114A (en) | Novel 6-fused heteroaryldihydropyrimidines for the treatment and prophylaxis of hepatitis b virus infection | |
| MX392270B (es) | Oxisteroles sustituidos en c7 y metodos de uso de los mismos. | |
| EA201891278A1 (ru) | Гетероциклические индолы для применения при инфекции, вызванной вирусом гриппа | |
| MX2021001804A (es) | Compuestos de urea y composiciones como inhibidores de atpasa de smarca2/brm. | |
| EA201892246A1 (ru) | Производные аминотиазола, полученные в качестве противовирусных средств | |
| EA201891666A1 (ru) | Арилзамещенные пиримидины для применения при инфекции, вызванной вирусом гриппа | |
| EA202190055A1 (ru) | Производные пиразола в качестве ингибиторов malt1 | |
| EA202190464A1 (ru) | Замещенные бензимидазолы в качестве ингибиторов pad4 | |
| PH12017502009A1 (en) | Novel sulfonimidoylpurinone compounds and derivatives for the treatment and prophylaxis of virus infection | |
| BR112016002638A2 (pt) | novos aza-oxo-indóis para o tratamento e profilaxia de infecção pelo virus sincicial respiratório | |
| EA201790234A1 (ru) | 2'-хлораминопиримидиноновые и пиримидиндионовые нуклеозиды |